Nice piece in Digital Health Insights by Carrie Pallardy looking at the murky world of direct-to-consumer #telemedicine and GLP-1s, especially companies providing compounded GLP-1s to patients who may not truly need them
Analysts at the time were bullish about these findings, with BMO Capital Markets noting that orforglipron achieved injectable like efficacy. Study participants also lost 7.9% body weight after orforglipron treatment, as compared with 1.6% in placebo
If you have experienced symptoms of vision loss while taking Ozempic or another semaglutide medication, its crucial to seek medical care as soon as possible
Yes, family history of papillary or follicular thyroid cancer does not contraindicate GLP-1 therapy
With consistent use, the Ultimate GLP-1 helps reduce visceral fat and stomach circumference when paired with a healthy diet and exercise, curbs cravings, appetite, hunger, and snacking, and enhances lean mass
7.5 2.4, p -value 0.046) [28]